Note 14 - Notes Payable (Details Textual) - USD ($)			1 Months Ended							3 Months Ended	6 Months Ended		9 Months Ended	12 Months Ended
Note 14 - Notes Payable (Details Textual) - USD ($)	May 05, 2023	Jan. 20, 2022	Sep. 30, 2022	Aug. 31, 2022	Jul. 31, 2022	Sep. 30, 2021	Apr. 30, 2021	Sep. 30, 2019	Jan. 31, 2019	Jun. 30, 2022	Dec. 31, 2023	Jun. 30, 2023	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021	Aug. 30, 2022	Mar. 06, 2019	Dec. 31, 2018
Debt Instrument, Face Amount				$ 2,800,000
Common Stock, Par or Stated Value Per Share (in dollars per share)											$ 0.0001		$ 0.0001	$ 0.0001
Gain (Loss) on Extinguishment of Debt											$ (0)	$ 0	$ 0	$ 953,000
Interest Expense, Debt											29,000	100,000		300,000
Other Finance Costs												(0)	(0)	147,000
Long-Term Debt, Gross											1,255,000		1,255,000	4,296,000
Debt Instrument, Unamortized Discount											(0)		(0)	1,820,000
Debt Conversion, Converted Instrument, Amount											0	1,195,000		0
Warrants and Rights Outstanding																$ 6,100,000
Embedded Derivative, Fair Value of Embedded Derivative Liability																2,000,000
Derivative, Gain on Derivative														284,000
Notes Payable											1,255,000		1,255,000	2,476,000
Property, Plant and Equipment, Net											3,284,000		3,284,000	2,583,000
Notes Payable, Current											145,000		145,000	227,000
Pharmacy Equipment [Member]
Property, Plant and Equipment, Net											22,000		22,000	38,000
Next Plat Investors [Member]
Issuance Of Common Stock For Debt Modification Agreement Shares (in shares)				105,000
Amortization											0	128,000		131,000
Common Stock Purchase Warrants [Member]
Class of Warrant or Right, Outstanding (in shares)	330,000
Warrants and Rights Outstanding	$ 700,000											4,600,000				$ 4,600,000
Debt Conversion Agreement [Member]
Debt Instrument, Convertible, Conversion Price (in dollars per share)	$ 2.2
Debt Conversion, Converted Instrument, Amount	$ 2,900,000
Debt Conversion, Converted Instrument, Shares Issued (in shares)	1,312,379
Debt Conversion, Converted Instrument, Conversion Expense												5,200,000
Debt Conversion, Converted Instrument, Debt Issuance Costs and Debt Discount												1,700,000
Debt Conversion, Converted Instrument, Loss From Inducement												$ 1,100,000
Iliad Research And Trading L P [Member]
Derivative, Gain (Loss) on Derivative, Net														914,000
Derivative Liability														1,477,400
Amortization of Debt Discount (Premium)														286,000
Securities Purchase Agreement [Member] \| Iliad Research And Trading L P [Member]
Debt Instrument, Face Amount																	$ 3,310,000
Debt Instrument, Interest Rate, Stated Percentage																	10.00%
Common Stock, Par or Stated Value Per Share (in dollars per share)																	$ 0.0001
Gain (Loss) on Extinguishment of Debt															$ 180,000
Debt Instrument, Extension Fee		$ 46,000
Debt Instrument, Increase (Decrease), Net		100,000								$ 237,000					(180,000)
Proceeds from Notes Payable															175,000
Interest Expense, Debt		100,000
Other Finance Costs		$ 46,000								$ 101,000
Long-Term Debt, Gross															2,144,000
Interest Payable															$ 833,000
Next Plat Investors [Member]
Debt Instrument, Face Amount														2,800,000
Debt Instrument, Interest Rate, Stated Percentage				5.00%
Interest Payable														47,000
Debt Instrument, Convertible, Conversion Price (in dollars per share)				$ 4
Debt Instrument, Unamortized Discount														1,800,000
Debt Instrument, Maturity Date				Aug. 31, 2027
Mortgage Note Payable Commercial Bank Collateralized [Member]
Debt Instrument, Interest Rate, Stated Percentage																		4.75%
Long-Term Debt, Gross											1,140,000		1,140,000	1,226,000
Secured Debt																		$ 1,530,000
Repayments of Debt									$ 11,901
Note Payable Collateralized Pharmacy Equipment [Member]
Debt Instrument, Interest Rate, Stated Percentage						6.90%		6.50%
Debt and Lease Obligation								$ 85,000
Debt Instrument, Periodic Payment						$ 331		$ 2,015
Notes Payable											0		0	16,000
Property, Plant and Equipment, Net														16,000
Payments to Acquire Machinery and Equipment							$ 30,000
Notes Payable, Current											6,000		6,000	9,000
Note Payable Collateralized [Member]
Long-Term Debt, Gross											90,000		90,000	137,000
Note Payable Collateralized [Member] \| Pharmacy Equipment [Member]
Debt Instrument, Interest Rate, Stated Percentage					8.78%
Property, Plant and Equipment, Net											71,000		71,000	84,000
Payments to Acquire Machinery and Equipment					$ 90,000
Notes Payable, Current											74,000		74,000	90,000
Note Payable Collateralized [Member] \| Pharmacy Equipment [Member] \| Sixty Monthly Payments [Member]
Debt Instrument, Periodic Payment					$ 1,859
Note Payable Collateralized [Member] \| Vehicles [Member]
Debt Instrument, Interest Rate, Stated Percentage			8.29%
Debt Instrument, Periodic Payment			$ 1,143
Notes Payable											10,000		10,000	22,000
Property, Plant and Equipment, Net											$ 18,000		$ 18,000	$ 23,000
Payments to Acquire Machinery and Equipment			$ 25,000

Progressive Care Inc. 10-K